FREE TO MOVE is more than just our comprehensive joint health portfolio. It’s how we want every horse to feel.
Learn more about degenerative joint disease, and discover our full joint health product portfolio at the link below.
Surpass®
(1% diclofenac sodium)
The only topical equine NSAID with patented WISDOM® technology that targets pain at the source.
Details
SURPASS is the only FDA-approved topical NSAID medication that modifies both clinical signs and progression of osteoarthritis in horses.1
A horse’s joints often need medical support in order to relieve the pain and inflammation associated with equine osteoarthritis. Untreated osteoarthritis can cause poor performance, lameness and long-term effects on quality of life.
SURPASS for horses is a unique topical nonsteroidal anti-inflammatory drug (NSAID) that provides pain relief directly at the site of inflammation in tarsal, carpal, metacarpophalangeal, metatarsophalangeal and proximal interphalangeal (hock, knee, fetlock and pastern) joints in horses. This targeted treatment minimizes the risk of the potential side effects that come with systemic NSAIDS.
Formulated with unique WISDOM® liposomal technology, SURPASS cream penetrates the skin barrier and provides sustained release in a way that alternatives don't. This means relief for your horses in fewer applications. Help manage your horse’s joint health by asking your veterinarian for a product you can apply yourself after you’ve left the clinic.
NSAIDs should only be administered under the direction of a licensed professional. SURPASS topical cream is only approved for use in horses, and has not been evaluated in breeding, pregnant or lactating horses, or in horses under 1 year of age. Do not exceed the recommended dose. Wear gloves when administering SURPASS.
Features & Benefits
Features
-
The only approved topical NSAID medication that modifies both clinical signs and progression of osteoarthritis in horses1
-
Targeted treatment minimizes the risk of the potential side effects that come with systemic NSAIDS
-
Formulated with unique WISDOM® liposomal delivery technology, which helps enhance local absorption of the active ingredient, diclofenac, at the site of inflammation
Benefits
-
Disease-modifying effects–shown to increase glycosaminoglycan concentration in cartilage and decrease bone sclerosis in osteoarthritis-affected joints1
-
Symptom-modifying effects shown to improve lameness scores following treatment with SURPASS
-
Penetrates the skin barrier and provides sustained release in ways that alternatives don't, necessitating fewer applications
Dosage & Administration
SURPASS can only be used by or on the order of a veterinarian. Once prescribed, SURPASS is made for easy administration by an owner. Apply a five-inch (5") ribbon of SURPASS topical cream, and rub the cream thoroughly into the hair, covering the affected joint until it disappears. Use it twice daily for up to ten (10) days.
Do not exceed the recommended dose. Wear gloves when administering SURPASS. If direct contact with skin occurs, wash immediately with soap and water. For more information, please read the SURPASS Product Label.
Resources
Safety Information
Like any medication, non-steroidal anti-inflammatory drugs (NSAIDs) such as SURPASS may cause side effects. These are usually mild and affect primarily the gastrointestinal system, but more serious side effects, such as diarrhea and renal toxicity, may occur. NSAIDs should only be administered under the direction of a licensed professional. SURPASS topical cream is only approved for use in horses, and has not been evaluated in breeding, pregnant, or lactating horses or in horses under 1 year of age. Do not exceed the recommended dose. Wear gloves when administering SURPASS. If direct contact with skin occurs, wash immediately with soap and water.
Not your typical topical.
Other products contain diclofenac sodium, but they don’t have WISDOM®, the patented and proven multilayered liposomal delivery technology found only in SURPASS.1
References
1 Frisbie DD, Mcllwraith CW, Kawcak CE, Werpy NM, Pearce, GL, WITH et al. Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis. AJVR 2009;70(2):210–215
2 Caldwell FJ, Mueller POE, Lynn RC, Budsberg SC. Effect of topical application of diclofenac liposomal suspension on experimentally induced subcutaneous inflammation in horses. Am J Vet Res 2004;65(3):271–276.
3 SURPASS (1% diclofenac sodium) [Freedom of Information Summary]. Greensboro, NC: IDEXX Pharmaceuticals, Inc.; 2004.
Trademarks
SURPASS® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc. WISDOM® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-EQU-0117-2021-V2